Australia markets open in 4 hours 52 minutes

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.3000-0.2200 (-6.16%)
As of 03:02PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 8.80M
Enterprise value 3.44M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.92
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.16

Trading information

Stock price history

Beta (5Y monthly) 1.29
52-week change 3-77.65%
S&P500 52-week change 321.83%
52-week high 321.2500
52-week low 33.1992
50-day moving average 36.5221
200-day moving average 37.7575

Share statistics

Avg vol (3-month) 329.96k
Avg vol (10-day) 342.67k
Shares outstanding 52.52M
Implied shares outstanding 62.52M
Float 82.23M
% held by insiders 14.71%
% held by institutions 113.87%
Shares short (28 Mar 2024) 486.6k
Short ratio (28 Mar 2024) 41.93
Short % of float (28 Mar 2024) 43.55%
Short % of shares outstanding (28 Mar 2024) 43.44%
Shares short (prior month 29 Feb 2024) 418.08k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 319 Dec 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-4,695.88%

Management effectiveness

Return on assets (ttm)-75.71%
Return on equity (ttm)-130.94%

Income statement

Revenue (ttm)733.87k
Revenue per share (ttm)0.41
Quarterly revenue growth (yoy)-63.40%
Gross profit (ttm)N/A
EBITDA -21.39M
Net income avi to common (ttm)-21.24M
Diluted EPS (ttm)-11.8500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.48M
Total cash per share (mrq)2.17
Total debt (mrq)115.25k
Total debt/equity (mrq)1.21%
Current ratio (mrq)3.12
Book value per share (mrq)4.04

Cash flow statement

Operating cash flow (ttm)-16.04M
Levered free cash flow (ttm)-8.75M